Early Clinical Trials in HGF/C-MET Targeted Therapy - Dr. Johanna Bendell, Dr. David Spigel

This Investigator Insights discusses the pathophysiology of the cMET pathway in a variety of cancers, the agents under investigation that target aberrations in cMET signaling, practical considerations in integrating these agents into clinical practice, recent clinical trial results, and ongoing phase III studies.

Earn accreditation for this activity at http://elc.imedex.com/ELC/Acti....vity-Detail.aspx?act

© 2012 Imedex, LLC.